07/11/2024  13:43:33 Var. +6.45 Volume Denaro19/07/2024 Lettera19/07/2024 Capitalizzazione di mercato Dividend Y. Rapporto P/E
234.45EUR +2.83% 205
Fatturato: 47,992.25
-Quantità in denaro: - -Quantità in lettera: - 14.44 bill.EUR 0.32% 78.13

Descrizione business

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Joachim Kreuzburg
Consiglio di amministrazione
Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer
Consiglio di sorveglianza
Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth
 

Dati aziendali

Name: Sartorius AG
Indirizzo: Otto-Brenner-Str. 20,D-37079 Goettingen
Telefono: +49-551-308-0
Fax: +49-551-308-3289
E-mail: info@sartorius.com
Internet: www.sartorius.de
Industria: Technology
Settore: Other Technology Industries
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: 40.81%
Data dell'IPO: 10/07/1990

Rapporti con gli investitori

Name: Petra Kirchhoff
IR telefono: +49-551-308-1686
IR Fax: -
IR e-mail: petra.kirchhoff@sartorius.com

Principali azionisti

FreeFloat
 
72.00%
Bio-Rad Laboratories
 
28.00%